Evidence map›Paper›PMID 36411354›Full record

ArticleNature microbiology2022

A large-scale genomic snapshot of Klebsiella spp. isolates in Northern Italy reveals limited transmission between clinical and non-clinical settings.

Harry A Thorpe, Ross Booton, Teemu Kallonen, Marjorie J Gibbon, Natacha Couto, Virginie Passet, Sebastián López-Fernández, Carla Rodrigues, Louise Matthews, Sonia Mitchell and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
8.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Pathogens (Basel, Switzerland) · 2024
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Variable chlorhexidine MICs acrossAntimicrobial agents and chemotherapy · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. A One Health study ofMicrobial genomics · 2026
    Article
  13. Article
  14. Phenotypic and genome-based characterization ofFrontiers in microbiology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 5 countries.

Harry A ThorpeDepartment of Biostatistics, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0001-5895-3232
Ross BootonBristol Veterinary School, University of Bristol, Bristol, UK.
Teemu KallonenDepartment of Clinical Microbiology, Turku University Hospital, Turku, Finland.ORCID http://orcid.org/0000-0003-1741-6486
Marjorie J GibbonThe Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, UK.ORCID http://orcid.org/0000-0002-5124-6081
Natacha CoutoThe Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, UK.ORCID http://orcid.org/0000-0002-9152-5464
Virginie PassetInstitut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Sebastián López-FernándezInstitut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Carla RodriguesInstitut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Louise MatthewsBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Sonia MitchellBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0003-1536-2066
Richard ReeveBoyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0003-2589-8091
Sophia DavidParasites and Microbes, Wellcome Sanger Institute, Cambridge, UK.
Cristina MerlaMicrobiology and Virology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.ORCID http://orcid.org/0000-0003-2986-6644
Marta CorbellaMicrobiology and Virology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.ORCID http://orcid.org/0000-0002-0969-6484
Carolina FerrariMicrobiology and Virology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
Francesco ComandatoreRomeo ed Enrica Invernizzi Pediatric Research Center, Department of Biomedical and Clinical Sciences Luigi Sacco, Università di Milano, Milan, Italy.
Piero MaroneMicrobiology and Virology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.
Sylvain BrisseInstitut Pasteur, Université Paris Cité, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.
Davide Sassera *Department of Biology and Biotechnology, Università di Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0003-0442-5252
Jukka Corander *Department of Biostatistics, University of Oslo, Oslo, Norway.
Edward J Feil *The Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, UK. e.feil@bath.ac.uk.ORCID http://orcid.org/0000-0003-1446-6744
Institut Pasteur · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITGlasgow Centre for Population Health · GBUniversity of Bath · GBTurku University Hospital · FIUniversity of Bristol · GBUniversity of Helsinki · FIUniversity of Oslo · NOUniversity of Pavia · ITWellcome Sanger Institute · GB

Funding

Medical Research Council MR/R00241X/1
6 · The paper itself

Abstract

The Klebsiella group, found in humans, livestock, plants, soil, water and wild animals, is genetically and ecologically diverse. Many species are opportunistic pathogens and can harbour diverse classes of antimicrobial resistance genes. Healthcare-associated Klebsiella pneumoniae clones that are non-susceptible to carbapenems can spread rapidly, representing a high public health burden. Here we report an analysis of 3,482 genome sequences representing 15 Klebsiella species sampled over a 17-month period from a wide range of clinical, community, animal and environmental settings in and around the Italian city of Pavia. Northern Italy is a hotspot for hospital-acquired carbapenem non-susceptible Klebsiella and thus a pertinent setting to examine the overlap between isolates in clinical and non-clinical settings. We found no genotypic or phenotypic evidence for non-susceptibility to carbapenems outside the clinical environment. Although we noted occasional transmission between clinical and non-clinical settings, our data point to a limited role of animal and environmental reservoirs in the human acquisition of Klebsiella spp. We also provide a detailed genus-wide view of genomic diversity and population structure, including the identification of new groups.

Indexed as

GenomicsKlebsiellaAnimalsCarbapenemsGenotypeHumansItalyCarbapenems

Identifiers

PMID36411354
PMCPMC9712112
OpenAlexW4309656930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.